Johnson & Johnson executives said in a conference call: It is expected that the expiration of the Affordable Care Act subsidy will not have a substantial impact on demand for medical technology products and medical surgery.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.